# A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.

> **NCT05752123** · NA · TERMINATED · sponsor: **EdiGene (GuangZhou) Inc.** · enrollment: 2 (actual)

## Conditions studied

- Transfusion Dependent Beta-Thalassaemia

## Interventions

- **BIOLOGICAL:** ET-01

## Key facts

- **NCT ID:** NCT05752123
- **Lead sponsor:** EdiGene (GuangZhou) Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-18
- **Primary completion:** 2024-01-29
- **Final completion:** 2025-03-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Development plan change
- **Last updated:** 2025-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05752123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05752123, "A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05752123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*